inVivo BioTech Services GmbH

https://www.invivo.de

InVivo Biotech Services GmbH (www.invivo.de) is headquartered in Hennigsdorf, Germany, near Berlin. InVivo Biotech is a molecular biology contract manufacturing organization (CMO), and a leading provider of monoclonal antibodies and recombinant proteins. InVivo Biotech also has significant experience in the development and production of innovative immunoassay components and research kits. In 2016, InVivo Biotech had revenues of approximately $5 million. InVivo Biotech is an ISO 9001 certified CMO with over 18 years of experience in mammalian cell culture and protein production. The company is providing monoclonal antibodies and recombinant proteins for its CMO customers, which include diagnostics companies, major research institutes and biopharmaceutical companies. Its production covers quantities from milligrams to grams of purified antibodies, including all subclasses of IgGs, IgMs and IgEs derived from a collection of more than 3,000 different hybridoma clones producing human, rat or mouse monoclonals. InVivo Biotech uses proprietary media for serum-free cultivation to facilitate highly productive and cost-effective processes in a high cell density fermentation process with yields up to 500 mg of antibody per liter of culture per day. InVivo Biotech provides a complete range of biotech services, from cloning, screening and recombinant expression of antigens to the generation of hybridoma cell lines, and from characterization of antibodies to final production of the developed monoclonal antibodies. InVivo Biotech's selection of bacterial, insect and mammalian protein expression systems provides a wide range of choices for various applications, taking into account specific CMO customer needs concerning quantity, bioactivity, structure, post-translational modifications and purity. Recombinant proteins are produced via stable or transient transfection. *

	Start	2001-01-01 renamed
	Group	Bruker (Group)
	Predecessor	inVivo Diagnostica Entwicklungsgesellschaft mbH
	Industry	contract manufacturing (diagnostics)
	Industry 2	immunoassay (diagnostics, antibody-antigen-test)
	Person	Morgenthaler, Nils G. (Bruker 201504 VP Medical Affairs at Bruker Daltonics division)
	Person 2	Karasch, Siegmund (InVivo Biotech Services 201105 Managing Director (CEO + COO) + Co-Founder)

	Region	Hennigsdorf
	Country	Germany
	Street	24a Neuendorfstr.
	City	16761 Hennigsdorf
	Tel	+49-3302-883-770
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	5,000,000 (revenues (2015) 2015-12-31)

		* Document for »About Section«: Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin.

		Record changed: 2023-12-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Bruker (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)